Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Could This Upcoming IPO Be the Next Teladoc?


It's always a lot more enticing to get in on an investment sooner rather than later -- buy early, and your long-term returns could be far greater. Teladoc Health (NYSE: TDOC) is an example of a stock that's been dominating the markets for years, and it's already up more than 130% in 2020. The S&P 500, by comparison, is still down 6% year to date.

But while the virtual health services provider is certainly an attractive investment, its shares have gotten a lot pricier. With the stock doing as well as it has this year, it's now trading at 24 times its revenue and more than 15 times its book value. And that's why instead of buying Teladoc, investors may want to consider investing in an upcoming IPO that could enjoy similar success: Amwell.

Amwell also provides telehealth services, and the company filed an IPO in early June. Its shares could be available on the markets as early as September.

Continue reading


Source Fool.com

Like: 0
Share

Comments